Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/16/21 → 11/30/26 |
Funding
- Fortrea Incorporated: $39,785.75
I8R-MC-IGBO: An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients with Type 1Diabetes Aged 1 to <4 years
- Bethin, Kathleen (PI)
Project: Research